Incretin-based therapy and the risk of diabetic foot ulcers and related events.

Nikki C C WerkmanJohanna H M DriessenOlaf H KlungelNicolaas S SchaperPatrick C SouvereinCoen D A Stehouwer Johannes T H Nielen

Published in: Diabetes, obesity & metabolism (2024)

Incretin-based therapy was associated with a lower risk of DFU and DFU-related outcomes. This suggests benefits for the use of this treatment in people at risk of DFU.

Keyphrases

stem cells
type diabetes
bone marrow
weight loss